$25-30 is normal valuation for 110. Does not include potential for any other drug in the pipeline.
$25-30 is where institutions will eliminate nearly all retail float.
$25-30 is the beginning of the unknown territory for resistence levels.
$25-30 is where the acquistion clock starts which will be orchestrated by institutions and board